SYK and Hepatic fibrosis: Especially, the SYK inhibition decreases the expression of TNF-α and IL-8 and suppresses mTOR signaling pathway as well as oxidative phosphorylation in myeloid cells, which protect from hepatic fibrosis effectively (Figure 2E) [42].